Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Visen Pharma Completes Phase III Trial of Therapy for Rare Thyroid Disease

publication date: Jan 12, 2023

Shanghai Visen Pharma completed a Phase III trial of its novel therapy that restores parathyroid hormone in patients with hypoparathyroidism (HP), a rare disease. The trial tested palopegteriparatide, a prodrug, in a double-blind, multi-center China trial. The company said HP is the only remaining endocrine deficiency condition that does not have a hormone replacement as standard treatment. Visen acquired rights to the drug from Copenhagen’s Ascendis Pharma, which formed Visen as a 50-50 JV with a syndicate of China VCs in 2018. Visen will now analyze the results of the Phase III trial. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here